Stock Analysis

Discover Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi Among 3 Stocks Estimated Below Fair Value

IBSE:AEFES
Source: Shutterstock

As global markets navigate a complex landscape marked by record highs in major U.S. indexes and divergent sector performances, investors are keenly observing the shifting dynamics between growth and value stocks. In this environment, identifying undervalued stocks can be particularly appealing as they may offer potential opportunities for those looking to balance their portfolios amid economic uncertainties.

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
Round One (TSE:4680)¥1264.00¥2527.2550%
NBT Bancorp (NasdaqGS:NBTB)US$50.26US$99.9349.7%
Gaming Realms (AIM:GMR)£0.36£0.7249.7%
West Bancorporation (NasdaqGS:WTBA)US$23.32US$46.3849.7%
EnomotoLtd (TSE:6928)¥1441.00¥2877.9749.9%
Aguas Andinas (SNSE:AGUAS-A)CLP289.40CLP576.0849.8%
Nidaros Sparebank (OB:NISB)NOK99.60NOK198.6249.9%
Shanghai INT Medical Instruments (SEHK:1501)HK$27.10HK$54.0049.8%
Zalando (XTRA:ZAL)€34.70€69.2849.9%
Akeso (SEHK:9926)HK$66.35HK$131.8849.7%

Click here to see the full list of 890 stocks from our Undervalued Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi (IBSE:AEFES)

Overview: Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi, along with its subsidiaries, is involved in the production, bottling, distribution, and sale of beer, malt, and non-alcoholic beverages both in Turkey and internationally with a market cap of TRY138.26 billion.

Operations: The company's revenue segments comprise TRY64.10 billion from the Beer Group and TRY95.24 billion from Soft Drinks.

Estimated Discount To Fair Value: 28.0%

Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi is trading at TRY 233.5, significantly below its estimated fair value of TRY 324.14, highlighting its undervaluation based on cash flows. Despite a decline in net income to TRY 5.6 billion for the third quarter compared to last year's TRY 13.9 billion, revenue growth is forecasted at a robust 40.3% annually, outpacing the Turkish market's expected growth rate and indicating potential long-term value amidst current profitability challenges.

IBSE:AEFES Discounted Cash Flow as at Dec 2024
IBSE:AEFES Discounted Cash Flow as at Dec 2024

Dr. Sulaiman Al Habib Medical Services Group (SASE:4013)

Overview: Dr. Sulaiman Al Habib Medical Services Group operates hospitals, medical complexes, day surgery centers, and pharmaceutical facilities in Saudi Arabia and internationally, with a market cap of SAR104.51 billion.

Operations: The company's revenue segments include Hospitals/Healthcare Facilities generating SAR8.14 billion and Pharmacies contributing SAR2.22 billion.

Estimated Discount To Fair Value: 20.5%

Dr. Sulaiman Al Habib Medical Services Group is trading at SAR 298.6, below its estimated fair value of SAR 375.61, indicating undervaluation based on cash flows. Earnings have grown consistently by 20.3% annually over the past five years, with revenue for Q3 reaching SAR 2.98 billion compared to last year's SAR 2.44 billion. Despite high debt levels, earnings are forecast to grow faster than the Saudi Arabian market, supporting its investment potential amidst robust financial performance.

SASE:4013 Discounted Cash Flow as at Dec 2024
SASE:4013 Discounted Cash Flow as at Dec 2024

Zalando (XTRA:ZAL)

Overview: Zalando SE operates an online platform for fashion and lifestyle products, with a market cap of €8.91 billion.

Operations: The company generates revenue from its online platform dedicated to fashion and lifestyle products, with segment adjustments amounting to €24.79 billion.

Estimated Discount To Fair Value: 49.9%

Zalando is trading at €34.7, significantly below its estimated fair value of €69.28, suggesting it is undervalued based on cash flows. The company reported Q3 sales of €2.39 billion and net income of €44.3 million, a notable turnaround from the previous year's loss. Earnings are forecast to grow 21.9% annually over the next three years, outpacing the German market's growth rate, despite a modest revenue growth forecast of 5.8%.

XTRA:ZAL Discounted Cash Flow as at Dec 2024
XTRA:ZAL Discounted Cash Flow as at Dec 2024

Summing It All Up

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com